Tissue Engineering: The Combination of Cells & Engineering - A Global Market Overview
Industry Experts
February 15, 2012 153 Pages - SKU: IDXP6809718
|
|
Countries covered: Global
Advancements of novel therapies in the fields of tissue engineering and regenerative medicine have opened up new avenues for addressing a range of major diseases such as cancer; skin; cardiovascular conditions; urology; dental; neurological disorders including Alzheimer's and Parkinson's; and other. Engineered tissues can be successfully constructed through the recreation of a biologically active extracellular environment in which the product can be developed. These technologies offer new hope for medical progress, and the economies of emerging nations have recognized the potential of tapping into these fast emerging fields to gain maximum mileage.
The global market for the therapeutic areas of Tissue Engineering analyzed in this study comprises Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other. Individual regions analyzed in the study includes the United States, Europe, Asia-Pacific and Rest of World. Estimated to value US$11 billion in 2012, the global market for tissue engineering is expected to touch US$27 billion by 2018.
This 153 page global market report includes 27 rich data tables, supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value by geographic regions and application areas.
The report covers the brief business profiles of 60 major players across the United States - 47; Europe - 10; Asia-Pacific - 2; and Rest of World - 1. The report also provides the listing of the companies engaged in the business related to Tissue Engineering. The global list covers the addresses, contact numbers and the website addresses of 364 companies.
|
- 1. INTRODUCTION
- 2. PRODUCT OUTLINE
- 2.1 Biomaterials
- 2.2 Cells
- 2.3 Biomolecules
- 2.4 Aspects of Engineering Design
- 2.5 Biomechanical Design Aspects
- 2.6 Informatics to Support Tissue Engineering
- 2.7 Stem Cell Research
- 2.8 Therapeutic Applications of Tissue Engineering and Regenerative Medicine
- 2.8.1 Orthopedic Applications
- 2.8.1.1 Bone Regeneration Using Orthopedic Tissue Engineering
- 2.8.1.2 Articular Cartilage Degeneration and Osteoarthritis, Repair, Regeneration and Transplantation
- 2.8.1.2.1 Cartilage Repair
- 2.8.1.2.2 Osteochondral Allograft Transplantation
- 2.8.2 Skin/Integumentary Applications
- 2.8.2.1 Burns
- 2.8.2.2 Diabetic Ulcers
- 2.8.2.3 Venous Ulcers
- 2.8.2.4 Plastic and Reconstructive Surgery
- 2.8.3 Oncology Applications
- 2.8.3.1 Cancer
- 2.8.3.2 Cancer Biology from Tissue Engineering’s Perspective
- 2.8.3.3 Tissue Engineering Technology Platforms’ Translation into Cancer Research
- 2.8.4 Cardiovascular Applications
- 2.8.4.1 Cardiac Tissue Engineering: An Overview
- 2.8.4.2 Identification of Basic Cell Responses
- 2.8.4.2.1 Materials and Degradation
- 2.8.4.2.2 Attachment
- 2.8.4.2.3 Stiffness
- 2.8.4.2.4 Diffusion and Porosity
- 2.8.4.2.5 Forces
- 2.8.4.3 3-Dimensional Tissue Engineering
- 2.8.4.4 Further 3-D Approaches and Considerations
- 2.8.4.5 Cardiovascular Tissue Engineering and Bioreactor Technology
- 2.8.4.6 Limiting Cells or Materials
- 2.8.5 Dental
- 2.8.5.1 Dental Tissue Regeneration through Tissue Engineering Strategy
- 2.8.5.2 Harvesting Teeth Created by Tissue Engineering
- 2.8.5.3 Research Goals Currently Targeted
- 2.8.5.4 Process of Tissue Engineering for Tooth Replacement: What Future Trends Indicate
- 2.8.6 Neurology Applications
- 2.8.6.1 Neural Tissue Engineering or Neuroregeneration
- 2.8.6.2 Biomaterial Scaffold Development for Nerve Tissue Engineering: Biomaterial Mediated Neural Regeneration
- 2.8.6.2.1 Response to Injury and Repair
- 2.8.6.2.2 Neural Cells’ Regeneration Potential
- 2.8.6.2.3 Regeneration Promoted through Growth Factor Delivery
- 2.8.6.2.4 Biomaterials in Nerve Regeneration
- 2.8.6.2.5 Polymeric Scaffolds as Extracellular Matrix Analogues
- 2.8.6.2.6 Geometric Indicators: Structure of Scaffolds
- 2.8.6.2.7 Nanofiber Properties and Electrospinning Technology
- 2.8.6.2.8 Alternate Approaches
- 2.8.6.2.9 Electrical Cues
- 2.8.7 Urological Applications
- 2.8.7.1 Conditions Affecting the Urological System
- 2.8.7.1.1 The Kidney
- 2.8.7.1.2 The Ureter
- 2.8.7.1.3 The Urinary Bladder
- 2.8.7.1.4 The Urinary Sphincters
- 2.8.7.1.5 The Urethra
- 2.8.7.2 Stem Cells Offering Promise in Urological Regenerative Medicine
- 2.8.7.3 Polymeric Materials and their Potential Applications in Urologic Regenerative Medicine
- 2.8.8 Organ Transplantation
- 2.8.8.1 Categories of Transplant
- 2.8.8.2 Major Organs and Tissues Transplanted
- 3. KEY MARKET TRENDS
- What Lies in Store for Cartilage Regeneration Stem Cells
- Improved Scaffold for Bone Tissue Engineering Developed by Iranian Researchers
- Magnetic Levitation for Bio-Assembling in 3-D
- UK’s Footing in Regenerative Medicine Gaining Pace
- Chondrogenesis and Cartilage Tissue Engineering: The Way Ahead
- Regenerative Medicine Evolving, though Investors Still Wary
- Scientific Innovation Announced by LifeNet Health’s Institute of Regenerative Medicine
- Skin Stem Cells to Cure Genetic Liver Disease
- Future Markets for Tissue Engineering and Cell Therapy
- Timescale for Development
- Tissue Engineering and Ultrasound Technologies
- Overview of Myocardial Tissue Engineering (MTE)
- Future of Bone Regeneration and Organ Printing
- New Tissue Engineering Technology on the Way for Patients with Osteoarthritis
- Leg Muscle Regenerated from Pig Bladder Cells
- Loading Device for Intervertebral Disc Tissue Engineering
- Rodent Spine Biomechanical Function Restored with Tissue-Engineered Intervertebral Discs
- Engineering Human Tissue Regeneration via Novel Method
- Heart Tissue Healing Assisted by New Nanotechnology
- Developing Bioengineered Veins with Tissue Engineered Vascular Grafts a Promising Prospect
- New Organs, New Hope for Children Offered by Regenerative Medicine
- TERM: A Consortium Formed by Eight European Regions to Focus on Bolstering Tissue Engineering and Regenerative Medicine Initiatives
- An Overview of Dental Pulp Tissue Engineering
- Bioactive Electrospun Scaffolds to Deliver Growth Factors and Genes for Tissue Engineering Applications
- Regenerative Medicine: Progress and Prospects
- “Bio-Legos”: An Innovation in Tissue Engineering
- Pioneering Tissue-Engineered Urethras Report Success
- 4. MAJOR MARKET PLAYERS
- Advanced Cell Technology Inc
- Aesculap/B. Braun
- Athersys Inc
- Baxter International Inc
- Bayer Healthcare Pharmaceuticals
- Biocomposites Ltd
- Biolife Solutions Inc
- Biomet Inc
- Biotissue Technologies GmbH
- Cardium Therapeutics
- Celgene Corporation
- Cellerant Therapeutics Inc
- Corcell Companies, Inc
- Cryobanks International Inc
- Cryo-Cell International, Inc
- Cryolife, Inc
- Cryo-Save Group N.V.
- Cytori Therapeutics Inc
- Depuy
- Eli Lilly and Co
- ES Cell International Pte Ltd
- Gamida Cell Ltd
- Genta, Inc
- Genzyme Biosurgery Corp
- Genzyme Corp
- Geron Corporation
- Glaxosmithkline Plc
- Histogenics Corp
- Incytu Inc
- Integra Lifesciences Inc
- International Stem Cell Corporation
- Johnson & Johnson Inc
- Kensey Nash
- Kinetic Concepts, Inc.
- Lifecell Corp
- Lifecord International Co Ltd
- Medtronic Sofamor Danek Inc
- Neostem, Inc.
- Novartis Ag
- Novo Nordisk A/S
- Organogenesis Inc.
- OSI Pharmaceuticals Inc
- Osiris Therapeutics Inc.
- Osteotech, Inc.
- Pfizer Inc
- Regenerative Sciences Institute
- RTI Biologics, Inc
- Sanofi-Aventis
- Smith & Nephew Ltd
- Stryker Corporation
- Synovis Life Technologies, Inc
- Synovis Orthopedic and Woundcare, Inc
- Tengion, Inc
- Thermogenesis Corp
- Tissue Engineering, Inc.
- Tissue Repair Company
- Viacord
- Viacyte, Inc.
- W.L. Gore & Associates
- Zimmer Holdings Inc
- 5. KEY BUSINESS TRENDS
- NeoStem Completes Amorcyte Acquisition
- British Stem Cell Center Given the Go Ahead
- Aragon Surgical, Inc Taken Over by Aesculap
- Cellectis Acquires Cellartis
- Advanced BioHealing, Inc Acquired by Shire plc
- ProChon BioTech Acquired by Histogenics
- Integra LifeSciences Takes Over SeaSpine
- Stryker Acquires Orthovita
- Medtronic’s Minority Stake in Tengion with a Focus on Regenerative Medicine Market
- Cardiogenesis Acquired by CryoLife
- Trial for Stem Cell-Based Therapy for IBD Commenced by Athersys-Pfizer
- BioTime Acquires Glycosan BioSystems
- Two Innovative Technologies Acquired by Boston Scientific
- Allograft Cancellous Sponge Introduced by Integra LifeSciences
- Eli Lilly in Partnership with the Juvenile Diabetes Research Foundation
- Cell Targeting, Inc Acquired by BioTime
- Boston Scientific Acquires Atritech
- Intelect Medical Taken Over by Boston Scientific
- Progenitor Cell Therapy Taken Over by NeoStem
- Avid Radiopharmaceuticals Taken Over by Eli Lilly
- Integra™ Endoscopic Gastroc Release System (EGR) Launched by Integra LifeSciences
- Integra LifeSciences Launches New Range of Surgical Spine Instruments
- Lilly Acquires Alnara Pharmaceuticals
- Celgene Acquires Abraxis BioScience Inc
- First Regenerative Medicine Product from Harvard Bioscience
- Novel Bioactive Scaffold from Drexel
- 6. GLOBAL MARKET OVERVIEW
- 6.1 Global Market Analysis by Therapeutic Area
- Chart 1: Global Tissue Engineering Market Analysis (2008-2018) by Therapeutic Area - Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other in USD Million
- Chart 2: Glance at 2008, 2013 and 2018 Global Tissue Engineering Market Share (%) by Therapeutic Area - Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other
- 6.2 Tissue Engineering Therapeutic Area Analysis by Global Region
- 6.2.1 Orthopedics
- Chart 3: Global Market Analysis of Tissue Engineering in Orthopedic Applications (2008-2018) by Geographic Region - United States, Europe, Asia-Pacific and Rest of World in USD Million
- Chart 4: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Orthopedic Applications by Geographic Region - United States, Europe, Asia-Pacific and Rest of World
- 6.2.2 Integumentary
- Chart 5: Global Market Analysis of Tissue Engineering in Integumentary Applications (2008-2018) by Geographic Region - United States, Europe, Asia-Pacific and Rest of World in USD Million
- Chart 6: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Integumentary Applications by Geographic Region - United States, Europe, Asia-Pacific and Rest of World
- 6.2.3 Oncology
- Chart 7: Global Market Analysis of Tissue Engineering in Oncology Applications (2008-2018) by Geographic Region - United States, Europe, Asia-Pacific and Rest of World in USD Million
- Chart 8: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Oncology Applications by Geographic Region - United States, Europe, Asia-Pacific and Rest of World
- 6.2.4 Cardiology
- Chart 9: Global Market Analysis of Tissue Engineering in Cardiology Applications (2008-2018) by Geographic Region - United States, Europe, Asia-Pacific and Rest of World in USD Million
- Chart 10: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Cardiology Applications by Geographic Region - United States, Europe, Asia-Pacific and Rest of World
- 6.2.5 Dental
- Chart 11: Global Market Analysis of Tissue Engineering in Dental Applications (2008-2018) by Geographic Region - United States, Europe, Asia-Pacific and Rest of World in USD Million
- Chart 12: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Dental Applications by Geographic Region - United States, Europe, Asia-Pacific and Rest of World
- 6.2.6 Neurology
- Chart 13: Global Market Analysis of Tissue Engineering in Neurology Applications (2008-2018) by Geographic Region - United States, Europe, Asia-Pacific and Rest of World in USD Million
- Chart 14: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Neurology Applications by Geographic Region - United States, Europe, Asia-Pacific and Rest of World
- 6.2.7 Other Therapeutic Areas
- Chart 15: Global Market Analysis of Tissue Engineering in Other Therapeutic Applications (2008-2018) by Geographic Region - United States, Europe, Asia-Pacific and Rest of World in USD Million
- Chart 16: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Other Therapeutic Applications by Geographic Region - United States, Europe, Asia-Pacific and Rest of World
- 7. REGIONAL MARKET OVERVIEW
- Chart 17: The Projection of Key Market Region in terms of Growth for Tissue Engineering by Geography - Asia-Pacific, South America, Europe and North America
- Chart 18: Global Tissue Engineering Market Analysis (2008-2018) by Geographic Region - United States, Europe, Asia-Pacific and Rest of World in USD Million
- Chart 19: Glance at 2008, 2013 and 2018 Global Tissue Engineering Market Share (%) by Geographic Region - United States, Europe, Asia-Pacific and Rest of World
- 7.1 THE UNITED STATES
- Chart 20: United States Tissue Engineering Market Analysis (2008-2018) by Therapeutic Area - Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other in USD Million
- Chart 21: Glance at 2008, 2013 and 2018 United States Tissue Engineering Market Share (%) by Therapeutic Area - Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other
- 7.2 EUROPE
- Chart 22: Western Europe Tissue Engineering Market Analysis (2008-2018) by Therapeutic Area - Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other in USD Million
- Chart 23: Glance at 2008, 2013 and 2018 Western Europe Tissue Engineering Market Share (%) by Therapeutic Area - Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other
- 7.3 ASIA-PACIFIC
- Chart 24: Asia-Pacific Tissue Engineering Market Analysis (2008-2018) by Therapeutic Area - Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other in USD Million
- Chart 25: Glance at 2008, 2013 and 2018 Asia-Pacific Tissue Engineering Market Share (%) by Therapeutic Area - Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other
- 7.4 REST OF WORLD
- Chart 26: Rest of World Tissue Engineering Market Analysis (2008-2018) by Therapeutic Area - Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other in USD Million
- Chart 27: Glance at 2008, 2013 and 2018 Rest of World Tissue Engineering Market Share (%) by Therapeutic Area - Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other
- 8. GUIDE TO THE INDUSTRY
- 8.1 North America
- 8.1.1 Canada
- 8.1.2 United States
- 8.2 Europe
- 8.2.1 Belgium
- 8.2.2 Cyprus
- 8.2.3 Denmark
- 8.2.4 Finland
- 8.2.5 France
- 8.2.6 Germany
- 8.2.7 Iceland
- 8.2.8 Ireland
- 8.2.9 Italy
- 8.2.10 Luxembourg
- 8.2.11 Spain
- 8.2.12 Sweden
- 8.2.13 Switzerland
- 8.2.14 The Netherlands
- 8.2.15 Turkey
- 8.2.16 United Kingdom
- 8.3 Asia-Pacific
- 8.3.1 Australia
- 8.3.2 China
- 8.3.3 Hong Kong
- 8.3.4 India
- 8.3.5 Japan
- 8.3.6 Malaysia
- 8.3.7 New Zealand
- 8.3.8 Singapore
- 8.3.9 South Korea
- 8.4 Rest of World
- 8.4.1 Argentina
- 8.4.2 Israel
- 9. ANNEXURE
- 9.1 Research Methodology
- 9.2 The Questionnaire
- 9.3 Feedback
More Global Tissue Engineering Reports
Global Tissue Engineering and Regeneration Market 2011-2015 by
Infiniti Research Limited
TechNavio’s analysts forecast the Global Tissue Engineering and Regeneration market to grow at a CAGR of 8.5 percent over the period 2011–2015. One of the ...
Growth Factors ( Blood And Tissue ) by
Global Industry Analysts
This report analyzes the worldwide markets for Growth Factors (Blood And Tissue) in US$ Million by the following growth factor types: Blood Growth Factors (Erythropoietins, ...
The 2009-2014 World Outlook for Growth Factors (blood and Tissue) by
Icon Group International, Inc.
This econometric study covers the world outlook for growth factors (blood and tissue) across more than 200 countries. For each year reported, estimates are given ...
Growth Factors (Blood And Tissue) by
Global Industry Analysts
This report analyzes the worldwide markets for Growth Factors (Blood And Tissue) in Millions of US$. The major product segments analyzed are Blood Growth Factors ...
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development by
Kalorama Information
With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new ...
See all reports like this >>
Share this report
Other tasks Related Markets Tissue Engineering Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
